Anti-Inflammatory Activity of Kurarinone Involves Induction of HO-1 via the KEAP1/Nrf2 Pathway.

HO-1 KEAP1 Nrf2 Sophora flavescens anti-inflammatory antioxidant kurarinone

Journal

Antioxidants (Basel, Switzerland)
ISSN: 2076-3921
Titre abrégé: Antioxidants (Basel)
Pays: Switzerland
ID NLM: 101668981

Informations de publication

Date de publication:
09 Sep 2020
Historique:
received: 07 07 2020
revised: 31 08 2020
accepted: 07 09 2020
entrez: 12 9 2020
pubmed: 13 9 2020
medline: 13 9 2020
Statut: epublish

Résumé

Kurarinone, a flavonoid isolated from the roots of

Identifiants

pubmed: 32916869
pii: antiox9090842
doi: 10.3390/antiox9090842
pmc: PMC7554885
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Japan Society for the Promotion of Science
ID : 18K06660, 18K16081, 20K07052
Organisme : Nagoya City University
ID : 2021103

Références

Oxid Med Cell Longev. 2018 Mar 13;2018:2492063
pubmed: 29643973
J Ethnopharmacol. 2015 Aug 22;172:10-29
pubmed: 26087234
Cells. 2020 Jan 09;9(1):
pubmed: 31936650
Int Immunopharmacol. 2018 Mar;56:105-112
pubmed: 29414639
Mol Cancer Ther. 2007 Jan;6(1):154-62
pubmed: 17237276
Mol Cell Biochem. 2002 May-Jun;234-235(1-2):249-63
pubmed: 12162441
Molecules. 2018 Jun 08;23(6):
pubmed: 29890668
Am J Nephrol. 2013;37(3):212-22
pubmed: 23467003
Brain. 2011 Mar;134(Pt 3):678-92
pubmed: 21354971
J Biol Chem. 2010 Jul 16;285(29):22576-91
pubmed: 20452972
J Ethnopharmacol. 2010 Feb 17;127(3):589-95
pubmed: 20034551
Biol Pharm Bull. 2008 May;31(5):908-15
pubmed: 18451517
J Clin Invest. 2015 Jul 1;125(7):2592-608
pubmed: 26011642
Molecules. 2019 Aug 27;24(17):
pubmed: 31461933
Proc Natl Acad Sci U S A. 2012 Aug 21;109(34):13561-6
pubmed: 22872865
Am J Respir Cell Mol Biol. 2007 Feb;36(2):166-74
pubmed: 16990612
Phytomedicine. 2004 Nov;11(7-8):666-72
pubmed: 15636183
Antioxid Redox Signal. 2018 Dec 10;29(17):1746-1755
pubmed: 28899203
Cell Rep. 2019 Jul 16;28(3):746-758.e4
pubmed: 31315052
Biol Pharm Bull. 2010;33(6):1019-23
pubmed: 20522970
J Biol Chem. 2019 Nov 1;294(44):16429-16439
pubmed: 31533987
Biochem Pharmacol. 2000 Oct 15;60(8):1121-8
pubmed: 11007950
Nat Cell Biol. 2010 Mar;12(3):213-23
pubmed: 20173742
Cancer Res. 2002 Sep 15;62(18):5196-203
pubmed: 12234984
Proc Natl Acad Sci U S A. 2005 Mar 22;102(12):4584-9
pubmed: 15767573
Nucleic Acids Res. 2007;35(21):7074-86
pubmed: 17942419
Trends Pharmacol Sci. 2017 Jul;38(7):592-607
pubmed: 28551354
Proc Natl Acad Sci U S A. 2009 Mar 31;106(13):5171-6
pubmed: 19286972
Free Radic Biol Med. 2015 Nov;88(Pt B):93-100
pubmed: 26117331
Mol Cell Biol. 2020 Jun 15;40(13):
pubmed: 32284348
Free Radic Biol Med. 2012 Aug 15;53(4):817-27
pubmed: 22732183
J Virol. 1998 Oct;72(10):8150-7
pubmed: 9733856
J Food Sci. 2013 Nov;78(11):T1830-4
pubmed: 24245902
Cancer Res. 2001 Apr 15;61(8):3299-307
pubmed: 11309284
ACS Chem Biol. 2016 Nov 18;11(11):3214-3225
pubmed: 27552339
Semin Oncol. 2016 Feb;43(1):146-153
pubmed: 26970133
Oxid Med Cell Longev. 2019 Jul 14;2019:9372182
pubmed: 31396308
Nat Commun. 2016 May 23;7:11624
pubmed: 27211851
J Mol Med (Berl). 2019 Apr;97(4):463-472
pubmed: 30820593
Trends Pharmacol Sci. 2013 Jun;34(6):340-6
pubmed: 23664668
Front Immunol. 2017 Jul 07;8:785
pubmed: 28736552
Immune Netw. 2009 Feb;9(1):12-9
pubmed: 20107533
Sci Rep. 2016 Oct 19;6:35483
pubmed: 27759037
Molecules. 2017 Oct 25;22(11):
pubmed: 29068394
Arch Pharm Res. 1997 Oct;20(5):491-5
pubmed: 18982496
Life Sci. 2016 Mar 1;148:183-93
pubmed: 26851532
FEBS Lett. 2017 Nov;591(21):3682-3691
pubmed: 28975618
Physiol Rev. 2006 Apr;86(2):583-650
pubmed: 16601269
Front Pharmacol. 2018 Mar 23;9:252
pubmed: 29628889
J Clin Biochem Nutr. 2019 Jan;64(1):1-12
pubmed: 30705506
Sci Rep. 2019 Jun 25;9(1):9245
pubmed: 31239473
Biol Pharm Bull. 2019;42(3):481-488
pubmed: 30828079

Auteurs

Sakiko Nishikawa (S)

Department of Cell Signaling, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya 467-8603, Japan.

Yasumichi Inoue (Y)

Department of Cell Signaling, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya 467-8603, Japan.
Department of Innovative Therapeutic Sciences, Cooperative Major in Nanopharmaceutical Sciences, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya 467-8603, Japan.

Yuka Hori (Y)

Department of Cell Signaling, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya 467-8603, Japan.

Chiharu Miyajima (C)

Department of Cell Signaling, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya 467-8603, Japan.
Department of Innovative Therapeutic Sciences, Cooperative Major in Nanopharmaceutical Sciences, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya 467-8603, Japan.

Daisuke Morishita (D)

Department of Cell Signaling, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya 467-8603, Japan.

Nobumichi Ohoka (N)

Division of Molecular Target and Gene Therapy Products, National Institute of Health Sciences, Kanagawa 210-9501, Japan.

Shigeaki Hida (S)

Department of Molecular and Cellular Health Sciences, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya 467-8603, Japan.

Toshiaki Makino (T)

Department of Pharmacognosy, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya 467-8603, Japan.

Hidetoshi Hayashi (H)

Department of Cell Signaling, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya 467-8603, Japan.
Department of Innovative Therapeutic Sciences, Cooperative Major in Nanopharmaceutical Sciences, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya 467-8603, Japan.

Classifications MeSH